ABCB7 | ATP-binding cassette, sub-family B (MDR/TAP), member 7 | Disease related genes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | Cancer-related genes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
ACSL1 | Acyl-CoA synthetase long-chain family member 1 | Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSM2A | Acyl-CoA synthetase medium-chain family member 2A | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ACSM2B | Acyl-CoA synthetase medium-chain family member 2B | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ACSS1 | Acyl-CoA synthetase short-chain family member 1 | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADAM20 | ADAM metallopeptidase domain 20 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
AFG3L2 | AFG3-like AAA ATPase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGPAT9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ALDH16A1 | Aldehyde dehydrogenase 16 family, member A1 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APOL2 | Apolipoprotein L, 2 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATG9A | Autophagy related 9A | Predicted membrane proteins
| | | | | Expressed in all |
ATP11A | ATPase, class VI, type 11A | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP13A2 | ATPase type 13A2 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP2A1 | ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ATP2C1 | ATPase, Ca++ transporting, type 2C, member 1 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP5F1 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ATP6V0A1 | ATPase, H+ transporting, lysosomal V0 subunit a1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
BAK1 | BCL2-antagonist/killer 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
BANP | BTG3 associated nuclear protein | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
BCAP29 | B-cell receptor-associated protein 29 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BCL2 | B-cell CLL/lymphoma 2 | Cancer-related genes Disease related genes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
BCL2L1 | BCL2-like 1 | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
BTN2A2 | Butyrophilin, subfamily 2, member A2 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BVES | Blood vessel epicardial substance | Predicted membrane proteins
| | | | | Tissue enhanced |
C9orf69 | Chromosome 9 open reading frame 69 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CATSPERD | Catsper channel auxiliary subunit delta | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CCDC51 | Coiled-coil domain containing 51 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CD151 | CD151 molecule (Raph blood group) | Blood group antigen proteins CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CD19 | CD19 molecule | CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CD34 | CD34 molecule | CD markers Predicted membrane proteins
| | | | | Expressed in all |
CD36 | CD36 molecule (thrombospondin receptor) | Cancer-related genes CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD37 | CD37 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CD81 | CD81 molecule | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD82 | CD82 molecule | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CERS2 | Ceramide synthase 2 | Predicted membrane proteins
| | | | | Expressed in all |
CFAP54 | Cilia and flagella associated 54 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLCC1 | Chloride channel CLIC-like 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
CLDN7 | Claudin 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CLDND1 | Claudin domain containing 1 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CMTM2 | CKLF-like MARVEL transmembrane domain containing 2 | Predicted membrane proteins
| | | | | Tissue enriched |
CMTM4 | CKLF-like MARVEL transmembrane domain containing 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
CMTM5 | CKLF-like MARVEL transmembrane domain containing 5 | Predicted membrane proteins
| | | | | Tissue enriched |